title: Connecting patient needs with treatment management.
abstract: OBJECTIVE
  To propose ideas for the development of a core strategy for monitoring patients with schizophrenia to ensure physical health and optimal treatment provision.
  
  
  METHODS
  A panel of European experts in the field of schizophrenia met in Bordeaux in June 2006 to discuss, 'Patient management optimisation through improved treatment monitoring.'
  
  
  RESULTS
  Key consensus from the discussion deemed that weight gain, oral health and ECG parameters were core baseline parameters to be monitored in all patients with schizophrenia. Further, an identification of a patient's own barriers to treatment alongside local health service strategies might comprise elements of an individualised management strategy which would contribute to optimisation of treatment. Any monitoring strategy should be kept simple to encourage physician compliance.
  
  
  CONCLUSIONS
  A practical solution to the difficulties of providing holistic patient care would be to suggest a limited set of physical parameters to be monitored by physicians on a regular basis.
authors.affiliation: Institute of Psychiatry, A School of King's College London, UK. joeb@lundbeck.com
authors.forename: R
authors.initials: R
authors.lastname: Kerwin
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003299:Cooperative Behavior; D019468:Disease Management; D004562:Electrocardiography / Q000187:drug effects; D005060:Europe; D006297:Health Services Accessibility; D006301:Health Services Needs and Demand; D006305:Health Status Indicators; D006801:Humans; D008134:Long-Term Care; D009909:Oral Health; D010348:Patient Care Team; D017410:Practice Guidelines as Topic; D011788:Quality of Life / Q000523:psychology; D012559:Schizophrenia / Q000175:diagnosis / Q000534:rehabilitation*; D012565:Schizophrenic Psychology; D015430:Weight Gain / Q000187:drug effects
chemical_list: D014150:Antipsychotic Agents